Stockreport

Paragon 28 Reports Second Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance

Paragon 28, Inc.  (FNA) 
PDF ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic ma [Read more]